ATE422370T1 - Modifizierte calciumphosphat-verbindung und injizierbare zusammensetzung enthaltend dieselbe - Google Patents

Modifizierte calciumphosphat-verbindung und injizierbare zusammensetzung enthaltend dieselbe

Info

Publication number
ATE422370T1
ATE422370T1 AT03717407T AT03717407T ATE422370T1 AT E422370 T1 ATE422370 T1 AT E422370T1 AT 03717407 T AT03717407 T AT 03717407T AT 03717407 T AT03717407 T AT 03717407T AT E422370 T1 ATE422370 T1 AT E422370T1
Authority
AT
Austria
Prior art keywords
injectable composition
compound
same
composition containing
calcium phosphate
Prior art date
Application number
AT03717407T
Other languages
English (en)
Inventor
Bruno Bujoli
Solen Josse
Jerome Guicheux
Pascal Janvier
Jean-Michel Bouler
Guy Daculsi
Original Assignee
Centre Nat Rech Scient
Univ Nantes
Inst Nat Sante Rech Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Nat Rech Scient, Univ Nantes, Inst Nat Sante Rech Med filed Critical Centre Nat Rech Scient
Application granted granted Critical
Publication of ATE422370T1 publication Critical patent/ATE422370T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/02—Inorganic materials
    • A61L27/12—Phosphorus-containing materials, e.g. apatite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/216—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials with other specific functional groups, e.g. aldehydes, ketones, phenols, quaternary phosphonium groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/432—Inhibitors, antagonists
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602—Type of release, e.g. controlled, sustained, slow

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
AT03717407T 2002-03-04 2003-02-18 Modifizierte calciumphosphat-verbindung und injizierbare zusammensetzung enthaltend dieselbe ATE422370T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0202707A FR2836681B1 (fr) 2002-03-04 2002-03-04 Compose phosphocalcique modifie, composition injectable le contenant

Publications (1)

Publication Number Publication Date
ATE422370T1 true ATE422370T1 (de) 2009-02-15

Family

ID=27741420

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03717407T ATE422370T1 (de) 2002-03-04 2003-02-18 Modifizierte calciumphosphat-verbindung und injizierbare zusammensetzung enthaltend dieselbe

Country Status (10)

Country Link
US (2) US7521436B2 (de)
EP (1) EP1480687B1 (de)
JP (1) JP4248407B2 (de)
AT (1) ATE422370T1 (de)
AU (1) AU2003222575B2 (de)
CA (1) CA2477756C (de)
DE (1) DE60326122D1 (de)
ES (1) ES2322343T3 (de)
FR (1) FR2836681B1 (de)
WO (1) WO2003074098A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2836681B1 (fr) * 2002-03-04 2004-06-18 Centre Nat Rech Scient Compose phosphocalcique modifie, composition injectable le contenant
US7553827B2 (en) * 2003-08-13 2009-06-30 Depuy Spine, Inc. Transdiscal administration of cycline compounds
US7344716B2 (en) * 2003-05-13 2008-03-18 Depuy Spine, Inc. Transdiscal administration of specific inhibitors of pro-inflammatory cytokines
US20040229878A1 (en) * 2003-05-13 2004-11-18 Depuy Spine, Inc. Transdiscal administration of specific inhibitors of P38 kinase
US8273347B2 (en) * 2003-05-13 2012-09-25 Depuy Spine, Inc. Autologous treatment of degenerated disc with cells
US7429378B2 (en) * 2003-05-13 2008-09-30 Depuy Spine, Inc. Transdiscal administration of high affinity anti-MMP inhibitors
US8361467B2 (en) 2003-07-30 2013-01-29 Depuy Spine, Inc. Trans-capsular administration of high specificity cytokine inhibitors into orthopedic joints
US8895540B2 (en) * 2003-11-26 2014-11-25 DePuy Synthes Products, LLC Local intraosseous administration of bone forming agents and anti-resorptive agents, and devices therefor
US8071574B2 (en) 2005-02-22 2011-12-06 John Dennis Bobyn Implant improving local bone formation
WO2008005509A2 (en) * 2006-07-06 2008-01-10 Massachusetts Institute Of Technology Methods and compositions for altering biological surfaces
US8974801B2 (en) 2006-12-21 2015-03-10 Amphastar Pharmaceuticals Inc. Long term sustained release pharmaceutical composition containing aqueous suspension of bisphosphonate
EP1958649A1 (de) * 2007-02-14 2008-08-20 Graftys Injizierbarer Kalzium-Phospat-Zement zur Freisetzung eines Knochenschwund-Inhibitors
US8986696B2 (en) 2007-12-21 2015-03-24 Depuy Mitek, Inc. Trans-capsular administration of p38 map kinase inhibitors into orthopedic joints
US8882740B2 (en) * 2009-12-23 2014-11-11 Stryker Trauma Gmbh Method of delivering a biphosphonate and/or strontium ranelate below the surface of a bone
ES2893354T3 (es) * 2014-03-14 2022-02-08 Ecole Polytechnique Fed Lausanne Epfl Combinación partícula - agente activo que ayuda a la regeneración ósea
US10537658B2 (en) 2017-03-28 2020-01-21 DePuy Synthes Products, Inc. Orthopedic implant having a crystalline gallium-containing hydroxyapatite coating and methods for making the same
US10537661B2 (en) 2017-03-28 2020-01-21 DePuy Synthes Products, Inc. Orthopedic implant having a crystalline calcium phosphate coating and methods for making the same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5208234A (en) * 1992-03-10 1993-05-04 E. R. Squibb & Sons, Inc. Substituted imidazole phosphonic and phosphinic acid derivatives
FR2715853B1 (fr) * 1994-02-08 1996-04-26 Centre Nat Rech Scient Composition pour bio-matériau; procédé de préparation.
AU776555B2 (en) * 1999-02-09 2004-09-16 Sloan-Kettering Institute For Cancer Research Anti-resorptive bone cements and allogeneic, autografic, and xenografic bone grafts
FR2836681B1 (fr) * 2002-03-04 2004-06-18 Centre Nat Rech Scient Compose phosphocalcique modifie, composition injectable le contenant

Also Published As

Publication number Publication date
JP4248407B2 (ja) 2009-04-02
AU2003222575B2 (en) 2008-08-21
FR2836681A1 (fr) 2003-09-05
US7521436B2 (en) 2009-04-21
AU2003222575A1 (en) 2003-09-16
WO2003074098A1 (fr) 2003-09-12
EP1480687B1 (de) 2009-02-11
US8044037B2 (en) 2011-10-25
US20050282783A1 (en) 2005-12-22
CA2477756C (fr) 2010-02-02
DE60326122D1 (de) 2009-03-26
EP1480687A1 (de) 2004-12-01
FR2836681B1 (fr) 2004-06-18
ES2322343T3 (es) 2009-06-19
JP2005531510A (ja) 2005-10-20
CA2477756A1 (fr) 2003-09-12
US20090203648A1 (en) 2009-08-13

Similar Documents

Publication Publication Date Title
ATE422370T1 (de) Modifizierte calciumphosphat-verbindung und injizierbare zusammensetzung enthaltend dieselbe
EA200970307A1 (ru) Способ получения галогенидов n-алкилнальтрексона
EA200500877A1 (ru) Получение блоков галогенидов редкоземельных металлов
KR860000291A (ko) 결정성 칼슘 슈도모네이트의 제법
BRPI0506906A (pt) composição farmacêutica sólida estável, processos para a estabilização de um sal, e para a preparação de um sal cristalino, e, sal cristalino
HUP0204379A2 (en) Preparation of concrete accelerator
DE69916364D1 (de) Verfahren zur Herstellung von künstlichem Zeolith
ATE232508T1 (de) Umweltschonendes verfahren zur herstellung von natriumchloridkristallen
NO974306D0 (no) Hydrogenperoksydkomplekser av uorganiske salter og syntese derav
DE50307001D1 (de) Verwendung von Schichtsilikat-Intercalationsverbindungen mit erhöhtem Expansionsvolumen als Brandschutzadditiv
DK1697326T3 (da) Krystalform af en quinolinforbindelse og fremgangsmåde til fremstilling deraf
IS6435A (is) Aðferð til framleiðslu á sítalóprami
NO994110L (no) Fremgangsmaate ved fremstilling av stabile, ikke-hygroskopiske salter av L(-)-carnitin
ATE412627T1 (de) Herstellung und verwendung von iminodibernsteinsäureammoniummetallsalzen
HUP0300227A2 (hu) Eljárás nagy tisztaságú 2-szubsztituált -1-(hidroxi-etilidén)-1,1-biszfoszfonsavak és sóik előállítására
NO20073602L (no) Fremgangsmate for fremstilling av hoyrent meloksikam og meloksikamkaliumsalt
EA200702579A1 (ru) Способ получения розувастатина
BR9912842A (pt) Processo para a preparação de sal de cálcio de zofenopril
DE50008920D1 (de) Verfahren zur herstellung von verbindungen der valproinsäure
NO20073213L (no) Fremgangsmate for fremstilling av tiofenglykosidderivater
BR112015003090B1 (pt) método para seletivamente inibir bactéria redutora de sulfato, composição de gesso capaz de inibir proliferação de bactéria redutora de sulfato pelo dito método, material de solificação do tipo gesso, e material de construção do tipo gesso
ATE327218T1 (de) Verfahren zur herstellung von 1-methyl-3- nitroguanidin
JP2007145708A5 (de)
ZA200709019B (en) Fast-dissolving bentonite granulate
ATE274498T1 (de) Verfahren zur herstellung von benzocycloheptapyridin-11-one

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1480687

Country of ref document: EP